In the battle between two “agent” coding tools, the claude code of Anthrope and the Codex Cli de OpenAi, the latter seems to be promoting more will of developers than the first. That is at least in part because Anthrope has issued a demolition notices to a developer who tries to innovate the Claude Engineering Code, which is under a more restrictive use license than the Codex Cli.
Claude Code and Codex Cli are grief tools that achieve much of the same thing: allow developers to take advantage of the power of the AI models that are executed in the cloud to complete several coding tasks. Anthrope and Openai released them with the interior of others: each company competes to capture the valuable Mindshare developer.
The Codex Cli source code is available under an Apache 2.0 license that allows commercial distribution and use. That is in contrast to the Claude code, which is linked to the commercial license of Anthrope. That limits how it can be modified without an explicit permission of the company.
Anthrope also “obfuscó” the source code for the Claude code. In other words, the Claude code source code is not easily available. When a The developer obfuscated him and launched the source code in Github, Anthrope presented a DMCA complaint – A notification of copyright requesting the elimination of the code.
Developers In social networks No pleased For the movement, they said unfavorably compared to the deployment of Codex Cli de OpenAi. In the week more or less from the Codex Cli version, OpenAi has merged dozens of developer suggestions at the tool code base, including one that allows Codex Cli Touch AI models of rival suppliers – including anthropic.
Anthrope did not respond to a request for comments. To be fair to the laboratory, the Claude code is still in beta (and a little wrong); It is possible that Anthrope releases the source code under a permissive license in the future. Companies have many reasons to obfuscate the code, one of them being one of them.
It is a somewhat surprising public relations victory for Openai, which in recent months has moved away from open source launches in favor of patented and blocked products. It can be emblematic of a broader change in the laboratory approach; The Operai CEO, Sam Altman, said earlier this year, believed that the company has been on the “wrong side of history” when it comes to open source.
